Item 8.01 Other Events.

On March 8, 2021, Talis Biomedical Corporation (the "Company") issued a press release titled "Talis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis One™ COVID-19 Test." A copy of the Company's press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



                 Exhibit
                   No.     Description
                 99.1        Press Release dated March 8, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses